Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
40 | 31853 | 41.8 | 86% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
32 | 105649 | VIROLOGY//AIDS RESEARCH AND HUMAN RETROVIRUSES//HIV 1 |
Classes in level below (level 1) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | AIDS RESEARCH AND HUMAN RETROVIRUSES | Journal | 1833 | 51% | 8% | 2585 |
2 | HIV 1 | Author keyword | 873 | 31% | 8% | 2397 |
3 | AIDS | Journal | 362 | 20% | 5% | 1619 |
4 | CCR5 | Author keyword | 357 | 53% | 1% | 474 |
5 | GP41 | Author keyword | 327 | 75% | 1% | 235 |
6 | NEF | Author keyword | 276 | 68% | 1% | 244 |
7 | HIV 2 | Author keyword | 238 | 60% | 1% | 257 |
8 | SIV | Author keyword | 216 | 47% | 1% | 340 |
9 | V3 LOOP | Author keyword | 201 | 82% | 0% | 119 |
10 | GP120 | Author keyword | 181 | 44% | 1% | 310 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HIV 1 | 873 | 31% | 8% | 2397 | Search HIV+1 | Search HIV+1 |
2 | CCR5 | 357 | 53% | 1% | 474 | Search CCR5 | Search CCR5 |
3 | GP41 | 327 | 75% | 1% | 235 | Search GP41 | Search GP41 |
4 | NEF | 276 | 68% | 1% | 244 | Search NEF | Search NEF |
5 | HIV 2 | 238 | 60% | 1% | 257 | Search HIV+2 | Search HIV+2 |
6 | SIV | 216 | 47% | 1% | 340 | Search SIV | Search SIV |
7 | V3 LOOP | 201 | 82% | 0% | 119 | Search V3+LOOP | Search V3+LOOP |
8 | GP120 | 181 | 44% | 1% | 310 | Search GP120 | Search GP120 |
9 | ENFUVIRTIDE | 133 | 74% | 0% | 98 | Search ENFUVIRTIDE | Search ENFUVIRTIDE |
10 | MARAVIROC | 124 | 61% | 0% | 131 | Search MARAVIROC | Search MARAVIROC |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IMMUNODEFICIENCY VIRUS TYPE 1 | 1511 | 30% | 14% | 4304 |
2 | ENVELOPE GLYCOPROTEIN | 974 | 44% | 5% | 1681 |
3 | GP120 | 941 | 61% | 3% | 999 |
4 | HUMAN IMMUNODEFICIENCY VIRUS | 860 | 13% | 19% | 6078 |
5 | CORECEPTOR USAGE | 828 | 86% | 1% | 420 |
6 | TYPE 1 INFECTION | 818 | 48% | 4% | 1245 |
7 | SOLUBLE CD4 | 697 | 78% | 1% | 457 |
8 | HIV 1 INFECTION | 696 | 32% | 6% | 1795 |
9 | DISEASE PROGRESSION | 670 | 29% | 6% | 1931 |
10 | V3 LOOP | 662 | 72% | 2% | 527 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AIDS RESEARCH AND HUMAN RETROVIRUSES | 1833 | 51% | 8% | 2585 |
2 | AIDS | 362 | 20% | 5% | 1619 |
3 | RETROVIROLOGY | 84 | 26% | 1% | 283 |
4 | CURRENT OPINION IN HIV AND AIDS | 81 | 31% | 1% | 217 |
5 | JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 60 | 18% | 1% | 300 |
6 | JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 59 | 12% | 1% | 456 |
7 | CURRENT HIV RESEARCH | 54 | 25% | 1% | 188 |
8 | JOURNAL OF MEDICAL PRIMATOLOGY | 38 | 15% | 1% | 237 |
9 | JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY | 38 | 19% | 1% | 186 |
10 | RESEARCH IN VIROLOGY | 15 | 16% | 0% | 86 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy | 2014 | 49 | 149 | 88% |
Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease | 1999 | 1468 | 212 | 84% |
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies | 2005 | 596 | 108 | 94% |
Insights into the trimeric HIV-1 envelope glycoprotein structure | 2015 | 4 | 58 | 95% |
Antibodies in HIV-1 Vaccine Development and Therapy | 2013 | 84 | 101 | 89% |
Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies | 2004 | 502 | 145 | 96% |
Lessons from the RV144 Thai Phase III HIV-1 Vaccine Trial and the Search for Correlates of Protection | 2015 | 4 | 85 | 84% |
How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs? | 2015 | 4 | 36 | 83% |
The immune response during acute HIV-1 infection: clues for vaccine development | 2010 | 259 | 154 | 69% |
Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies | 2012 | 109 | 112 | 90% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AIDS | 282 | 24% | 3.3% | 1052 |
2 | DUKE HUMAN VACCINE | 170 | 63% | 0.5% | 171 |
3 | VACCINE | 166 | 26% | 1.8% | 560 |
4 | PARTNERS AIDS | 162 | 53% | 0.7% | 218 |
5 | IAVI NEUTRALIZING ANTIBODY | 154 | 87% | 0.2% | 75 |
6 | AARON DIAMOND AIDS | 131 | 45% | 0.7% | 220 |
7 | RETROVIROL | 114 | 34% | 0.9% | 279 |
8 | VIRAL PATHOGENESIS | 89 | 39% | 0.6% | 180 |
9 | RAGON | 86 | 48% | 0.4% | 132 |
10 | CLIN VIROIMMUNOL | 84 | 58% | 0.3% | 98 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000014802 | FELINE IMMUNODEFICIENCY VIRUS//CAPRINE ARTHRITIS ENCEPHALITIS VIRUS//FIV |
2 | 0.0000013684 | APOBEC3G//INTEGRASE//HIV 1 INTEGRASE |
3 | 0.0000013588 | ANTIRETROVIRAL THERAPY//HIV//NEVIRAPINE |
4 | 0.0000009013 | BACTERIAL VAGINOSIS//MICROBICIDES//MICROBICIDE |
5 | 0.0000008266 | LIPODYSTROPHY//HIV ASSOCIATED NEPHROPATHY//LIPOATROPHY |
6 | 0.0000007954 | ORAL TOLERANCE//DC SIGN//DENDRITIC CELLS |
7 | 0.0000006400 | PNEUMOCYSTIS CARINII//PNEUMOCYSTIS JIROVECII//PNEUMOCYSTIS CARINII PNEUMONIA |
8 | 0.0000006376 | HIV 1 PROTEASE//HIV PROTEASE//KNI 272 |
9 | 0.0000006228 | HLA B8 DR3//INTERDISCIPLINARY STUDIES SECT//AH 81 |
10 | 0.0000005927 | HTLV I//HTLV 1//HAM TSP |